1. Home
  2. VANI vs GHG Comparison

VANI vs GHG Comparison

Compare VANI & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

SELL

Current Price

$1.16

Market Cap

111.0M

Sector

Health Care

ML Signal

SELL

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

SELL

Current Price

$0.94

Market Cap

101.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
VANI
GHG
Founded
1998
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
101.9M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
VANI
GHG
Price
$1.16
$0.94
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $3.83
N/A
AVG Volume (30 Days)
★ 153.0K
17.7K
Earning Date
11-12-2026
08-24-2026
Dividend Yield
N/A
★ 6.32%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $4,000,000.00
N/A
Revenue This Year
N/A
$56.17
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.76
Revenue Growth
N/A
★ N/A
52 Week Low
$0.92
$0.91
52 Week High
$1.92
$2.10

Technical Indicators

Market Signals
Indicator
VANI
GHG
Relative Strength Index (RSI) 37.37 39.30
Support Level $1.15 $0.93
Resistance Level $1.25 $1.12
Average True Range (ATR) 0.04 0.04
MACD -0.00 -0.00
Stochastic Oscillator 4.32 38.38

Price Performance

Historical Comparison
VANI
GHG

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: